Pyrazinamide
(Canadian brand: Tebrazid)
Category:
Description:
Indications:
-
Active
tuberculosis (as part of a 6 month regimen consisting of isoniazid,
rifampin, and pyrazinamide given for 2 months, followed by isoniazid
and rifampin for 4 months)
-
After
treatment failure with other primary drugs in any form of active
tuberculosis
Contraindications:
-
Severe
liver disease
-
Acute
gout
Precautions:
-
Pregnancy
category C; excreted into breast milk
-
History
of gout, renal and hepatic function impairment
-
Alcoholism,
elderly
-
HIV,
infection (may require longer courses of therapy), diabetes mellitus
Adverse
Reactions (Side Effects):
-
CNS:
fever
-
GI:
anorexia, hepatotoxicity, nausea, vomiting
-
GU:
dysuria, interstitial nephritis (rare)
-
HEME:
blood clotting abnormalities, increased serum iron concentration,
porphyria, sideroblastic anemia, thrombocytopenia
-
METAB:
gout, hyperuricemia
-
MS:
arthralgia, myalgia
-
SKIN:
acne, photosensitivity, pruritus, rash, urticaria
|
Dosage:
Administered
orally
-
Adult: PO 15-30 mg/kg every day for 1st 2 months of 6 month regimen with
isoniazid and rifampin or as part of an individualized regimen for
drug-resistant disease, max 2g daily; alternatively 50-70 mg/kg can be
given twice weekly to improve compliance (base dose on lean body
weight)
-
Child: PO 15-40 mg/kg/day divided every 12-24 hours, max 2g daily;
alternatively 50-70 mg/kg based on lean body weight twice weekly, max
3g dose
|
The information contained here is an
abbreviated summary. For more detailed and complete information, consult the
manufacturer's product information sheets or standard textbooks
Source: Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington,
D.C., 20372-5300
This information is provided by The Brookside Associates. The Brookside
Associates, LLC. is a private organization, not affiliated with any governmental
agency. The opinions presented here are those of the author and do not
necessarily represent the opinions of the Brookside Associates or the Department
of Defense. The presence of any advertising on these pages does not constitute
an endorsement of that product or service by either the US Department of Defense
or the Brookside Associates. All material presented here is unclassified.
C. 2009, 2014, All Rights Reserved
|
|